Predictive hybrid paradigm for cytotoxic activity of 1,3,4-thiadiazole derivatives as CDK6 inhibitors against human (MCF-7) breast cancer cell line and its structural modifications: rational for novel cancer therapeutics

The dysregulation of cyclin-CDK6 interactions has been implicated in human breast cancer, providing a rationale for more therapeutic options. Recently, ATP-competitive inhibitors have been employed for managing breast cancer. These molecules, like most natural CDKs inhibitors, potently bind in the ATP-binding site of CDK6 to regulate trans-activation. Nonetheless, only a few numbers of these molecules are approved to mitigate breast cancer, thus, ensuring that the search for more selective inhibitors continues. In this study, we attempted to establish the selective predictive models for identifying potent CDK6 inhibitors against a human breast cancer cell-line using a dataset of fifty-two 1,3,4-thiadiazole derivatives. The significant eight descriptor hybrid QSAR models generated exhibited encouraging statistical attributes including R2> 0.70, Q²_LOO > 0.70, Q²_LMO > 0.60, Qfn2 > 0.6. Furthermore, the study designed new compounds based on the activity and structural basis for selectivity of compounds for CDK6. While demonstrating good potency and modest selectivity, the compound C16, which showed significantly high activity of 5.5607 µM and binding energy value of -9.0 Kcal/mol, was used as template for compounds design to generate 10 novel series of 1,3,4-thiadiazole analogues containing benzisoselenazolone scaffolds, with significant pharmacological activity and better selectivity for CDK6. By our rationale, four of the designed compounds (C16b, C16h, C16i, and C16j) with activity values of 6.2584 µM, 6.7812 µM, 6.4717 µM, and 6.2666 µM respectively, and binding affinities of -10.0 kcal/mol, -9.9 kcal/mol, -9.9 kcal/mol, and -9.9 kcal/mol respectively, may emerge as therapeutic options for breast cancer treatment after extensive in vitro and in vivo studies.Communicated by Ramaswamy H. Sarma.

Biosynthesis of zinc oxide nanoparticles using anjbar (root of Persicaria bistorta) extract and their cytotoxic effects on human breast cancer cell line (MCF-7)

Biosynthesis of nanoparticles (NPs) using biomass is now one of the best methods for synthesising NPs due to their nontoxic and biocompatibility. Plants are the best choice among all biomass to synthesise large-scale NPs. The objectives of this study were to synthesise zinc oxide nanoparticles (ZnO-NPs) using Anjbar (root of Persicaria bistorta) [An/ZnO-NPs] and investigate the cytotoxic and anti-oxidant effects. For this purpose, the An/ZnO-NPs were synthesised by using Bistort extract and characterised using UV-Visible spectroscopy, transmission electron microscope, field emission scanning electron microscope, x-ray diffraction and Fourier-transform infrared spectroscopy. The cytotoxic effects of the An/ZnO-NPs on MCF-7 cells were followed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays at 24, 48, and 72 h. Nuclear morphology changed and apoptosis in cells was investigated using acridine orange/propodium iodide (AO/PI) staining and flow cytometry analysis. The pure biosynthesised ZnO-NPs were spherical in shape and particles sizes ranged from 1 to 50 nm. Treated MCF-7 cells with different concentrations of ZnO-NPs inhibited cell viability in a time- and dose-dependent manner with IC50 about 32 μg/ml after 48 h of incubation. In flow cytometry analysis the sub-G1 population, which indicated apoptotic cells, increased from 12.6% at 0 μg/ml (control) to 92.8% at 60 μg/ml, 48 h after exposure. AO/PI staining showed that the treated cells displayed morphologic evidence of apoptosis, compared to untreated groups.

Anticancer potential of leaf and leaf-derived callus extracts of Aerva javanica against MCF-7 breast cancer cell line

Background

Aerva javanica is an exotic and medicinal plant in India.

Aim of the Study

The main goal of this study was to evaluate the antiproliferative properties of leaf and leaf-derived callus extracts against human breast cancer cell line MCF-7.

Methods

The plant parts were sequentially extracted with hexane, chloroform, ethyl acetate, acetone, and methanol. The extract was concentrated to yield the crude extract, which was tested for anticancer potentials. The anticancer potential of cytotoxic extracts was determined by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and DNA fragmentation assays in human breast cancer cell lines (MCF-7).

Results

All the tested extracts showed significant antiproliferative activities in a concentration- and time-dependent manner. The inhibitory concentration of extract was tested against target cell line, and the results show in vitro leaf of A. javanica has higher inhibitory effect against the tested cancer cells at lower concentration (about 11.89 and 22.45 μg/ml) followed by other samples extracts.

Conclusion

The results of the present study conclude in vitro plant sample having more potent anticancer property and support the need of further studies to isolate potential anticancer drug with cancer cell-specific cytotoxicity.